Discovery Ltd
Discovery Ltd operates as a life and health insurance provider within the South African financial sector, generating revenue primarily through insurance premiums and investment returns on policyholder funds.
Business. Discovery Ltd (DSYJ.J) operates in the Life & Health Insurance industry within the broader Financials sector. The company generates revenue primarily through a premium-income model, focusing on life and health insurance activities. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
Analyst recommendations
8 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
6Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Discovery Ltd (DSYJ.J) has undergone a significant structural update in its corporate taxonomy, now formally classified under the "Life & Health Insurance" activity within the broader "Financials" economic sector. This reclassification represents a medium-severity change in the company's profile, establishing a clearer baseline for its operational identity within the financial services landscape. Concurrently, the risk assessment framework for the entity has been initialized with specific metrics. Dilution risk is now categorized as "low," providing a defined parameter for equity stability concerns. In contrast, liquidity risk remains classified as "unknown," indicating that sufficient data to quantify trading or cash flow constraints is currently unavailable. These updates occur against a backdrop of minimal recent market noise, with cross-source signals showing negligible dispatch activity through mid-June 2026. The absence of significant analyst coverage, index membership, or disclosed top holders further underscores the limited current visibility into the company's market dynamics. The formalization of DSYJ.J’s sector and risk attributes matters as it establishes the foundational data points necessary for future comparative analysis. While the low dilution risk offers a stable equity outlook, the unknown liquidity status and lack of broader market engagement suggest that investors should monitor for subsequent data releases to refine their understanding of the company's financial health.
Signals & dispatch
Composite-score breakdown
Synthesis
Discovery Ltd (DSYJ.J) operates in the Life & Health Insurance industry within the broader Financials sector. The company generates revenue primarily through a premium-income model, focusing on life and health insurance activities. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
Discovery Ltd’s capital structure and liquidity position present significant assessment challenges due to the absence of balance-sheet inputs in the provided data set. The risk assessment explicitly flags that liquidity risk could not be assessed, citing no balance-sheet inputs and no going-concern language in source documents. While the company reports 682,491,619 basic and diluted shares outstanding, the lack of cash, debt, or working capital metrics prevents a standard liquidity ratio analysis. The dilution risk is currently assessed as low, suggesting no immediate pressure from share issuance or convertible instruments.
Profitability and return metrics are unavailable for direct comparison against industry cohort medians. The valuation snapshot and financial snapshot sections do not contain data on net income, operating margins, ROIC, or ROE. Consequently, it is not possible to determine whether Discovery Ltd’s profitability exceeds or lags the Life & Health Insurance industry standard based on the provided inputs. The absence of these core profitability drivers limits the ability to evaluate the efficiency of capital deployment within the insurance model.
Discovery Ltd (DSYJ.J) has undergone a significant structural update in its corporate taxonomy, now formally classified under the "Life & Health Insurance" activity within the broader "Financials" economic sector. This reclassification represents a medium-severity change in the company's profile, establishing a clearer baseline for its operational identity within the financial services landscape. Concurrently, the risk assessment framework for the entity has been initialized with specific metrics. Dilution risk is now categorized as "low," providing a defined parameter for equity stability concerns. In contrast, liquidity risk remains classified as "unknown," indicating that sufficient data to quantify trading or cash flow constraints is currently unavailable. These updates occur against a backdrop of minimal recent market noise, with cross-source signals showing negligible dispatch activity through mid-June 2026. The absence of significant analyst coverage, index membership, or disclosed top holders further underscores the limited current visibility into the company's market dynamics. The formalization of DSYJ.J’s sector and risk attributes matters as it establishes the foundational data points necessary for future comparative analysis. While the low dilution risk offers a stable equity outlook, the unknown liquidity status and lack of broader market engagement suggest that investors should monitor for subsequent data releases to refine their understanding of the company's financial health.
- Liquidity risk is unassessed due to missing balance-sheet data, creating a significant information gap for solvency evaluation.
- Analyst consensus is positive with a mean recommendation of 2.00 (Buy) and a mean price target of 286.46 ZAR.
- Dilution risk is low, indicating no immediate threat from share issuance or convertible securities.
- Profitability and return metrics are unavailable, preventing comparison against Life & Health Insurance industry medians.
- The company is clearly classified as a Life & Health Insurance provider with high confidence (0.92), but segment revenue details are missing.
- Geographic exposure is implied to be South African based on ZAR financials and JSE listing, but specific concentration data is not provided.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income +27,7% YoY; Net income +26,5% YoY.
- ▍Operating income +27,7% YoY
- ▍Net income +26,5% YoY
- ▍Free cash flow +30,3% YoY
Operating income +10,7% YoY; Net income +14,9% YoY.
- ▍Operating income +10,7% YoY
- ▍Net income +14,9% YoY
- ▍Free cash flow +0,1% YoY
Operating income +28,4% YoY; Net income +20,1% YoY.
- ▍Operating income +28,4% YoY
- ▍Net income +20,1% YoY
- ▍Free cash flow +12,2% YoY
Operating income +40,6% YoY; Net income +70,1% YoY.
- ▍Operating income +40,6% YoY
- ▍Net income +70,1% YoY
- ▍Free cash flow +74,4% YoY
Operating income ZAR 5.71B.
- ▍Operating income ZAR 5.71B
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 17,39 |
| Revenue | —no estimate | —no estimate | 43,2B ZAR |
| Operating income | —no estimate | —no estimate | 17,8B ZAR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Discovery Ltd Market data — financials · 2026-06-09
- Discovery Ltd Market data — analyst estimates · 2026-06-09
- Discovery Ltd Market data — ESG · 2026-06-09
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
4 tracked-field change(s) detected vs prior analysis; max severity: medium.
- Dilution risk— → lowlow
- Liquidity risk— → unknownlow
- Activity— → Life & Health Insurancemedium
- Economic sector— → Financialsmedium